The first drug designed with significant AI involvement, Rentosertib, has advanced to Phase III clinical trials. AI was utilized to identify the drug's target, generate its molecular structure, and assist in the trial design. However, human execution remains crucial in the clinical trial process. AI
IMPACT Demonstrates AI's growing capability in accelerating drug discovery and development pipelines.
RANK_REASON AI-assisted drug discovery reaching a significant clinical trial phase. [lever_c_demoted from research: ic=1 ai=1.0]
Read on Mastodon — fosstodon.org →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
